Kite Pharma Inc (KITE) - Financial and Strategic SWOT Analysis Review Summary Kite Pharma Inc (Kite Pharma) is a bio-pharmaceutical company that discovers and develops cancer immunotherapy products. The company concentrates on chimeric antigen receptors (CAR) and T cell receptors (TCR) engineered cell therapies. It offers KTE-C19 in a critical trial for the treatment of refractory, aggressive non-Hodgkin Lymphoma (NHL). Kite Pharma also provides early research and product development services....
Kite Pharma Inc (KITE) - Financial Analysis Review Summary Kite Pharma Inc (Kite Pharma) is a bio-pharmaceutical company which discovers and develops cancer immunotherapy products. The company focuses on chimeric antigen receptors (CAR) and T cell receptors (TCR) engineered cell therapies. It offers KTE-C19 in a critical trial for the treatment of refractory, aggressive non-Hodgkin Lymphoma (NHL). Kite Pharma also provides early research and product development services. GlobalData's Kite Pha...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.